biomarker discovery: prognosis and management of chronic ... discovery.pdf · diabetes, chronic...
TRANSCRIPT
![Page 1: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/1.jpg)
S
Biomarker Discovery: Prognosis and
Management of Chronic Diabetic Foot Ulcers
Joseph Colasurdo, BSDr. William M. Scholl College of Podiatric Medicine
July 29, 2017
![Page 2: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/2.jpg)
Disclosure of Conflicts of Interest
S No financial relationships to disclose
![Page 3: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/3.jpg)
Learning Objectives
S Deliver insight into the proteomic, biochemical, and molecular
mechanisms which instigate diabetic foot ulcerations
S Establish a foundation for the significance of translational
research within the field of podiatric medicine
S Fashion a framework for further investigation into biomarkers
for diabetic foot ulcerations
![Page 4: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/4.jpg)
Diabetes, Chronic Wounds and
U.S. Healthcare
S Cost of caring for chronic wounds exceeds $50 billion each year1
S Over 29 million individuals in the U.S. suffer from Diabetes2
S ~25% of all diabetics will develop at least on foot ulcer in their
lifetime
S From these patients, 12% will require a lower extremity amputation
S 50% 5-year survival rate after a lower extremity amputation
S Cost of treating a single chronic wound ≈ $70,000
![Page 5: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/5.jpg)
Intact
Skin
Remodeling • Wound closure
• Scar tissue
Phases of Acute Wound Healing
Remodeling • Wound closure
• Scar tissue
Migration – Proliferation• Granulation tissue
• ECM synthesis
• New blood vessel formation
• Re-epithelialization
![Page 6: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/6.jpg)
Phases of Chronic Wound Healing
![Page 7: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/7.jpg)
The Complicated Story of
Diabetic Foot Ulcers
Nutritional
Status
Autonomic
Neuropathy
Macrovascular
disease
Biomechanical
Abnormalities
Trauma
Lifestyle
Motor
Neuropathy
Bone
Infection
Limited joint
mobility
Microvascular
disease
Soft tissue
InfectionEdema
ImmunodeficiencyArterial
Disease
Sensory
NeuropathyNeuropathic
Osteoarthropathy
(Charcot foot)
???Allergens
Arterial
disease
Hyperglycemia
![Page 8: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/8.jpg)
Cytokines in Acute Wound
Healing
• Keratinocytes
• Endothelial cells
• Fibroblasts
• Macrophages
• Myofibroblasts
• Macrophages
• Platelets
• Neutrophils
• Lymphocytes
• Macrophages
• TGF-beta
• MMPs
• EGF
• KGF
• VEGF
• FGF
• FN
• MMPs
• TIMPs
• TGF-beta
• TNF-alpha
• IL-1 beta
• IL-4
• IL-6
• MCP-1
![Page 9: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/9.jpg)
Hypothesis
Prior research has demonstrated that different cell types are present
throughout different phases of wound healing
We understand that each cell type produces specific cytokines
Cytokine abundance within the wound environment can predict the
prognosis of the wound
![Page 10: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/10.jpg)
Aim
S Prognosis of chronic foot ulcer healing through identification of
biomarkers
S Use of prognostic cytokine biomarkers in the clinical treatment of
chronic ulcers to better patient quality of life
![Page 11: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/11.jpg)
Methodology
Exclusion Criteria• Unable to provide
informed consent
• Active Neuropathic
Arthropathy
• Soft tissue infection• Untreated Osteomyelitis
Inclusion Criteria• Diagnosed with
Diabetes Mellitus
• Chronic diabetic foot
ulcer (>4 weeks) with
an area >1cm2
![Page 12: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/12.jpg)
Patient/Wound Overview
S 36 wounds from 29 patients
S Average Age 59 (30-73)
S 82% Male, 18% Female
S Ulcer locations: Sub 1st, 2nd and 5th metatarsal heads, plantar
aspect of the calcaneus, Chopart’s amputation, anterior aspect
of the tibia, distal to the medial malleolus
![Page 13: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/13.jpg)
Methodology
![Page 14: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/14.jpg)
Luminex 18 Cytokine Analysis
S Performed at the Cytoplex Multiplex-Core Facility, Department of Obstetrics and Gynecology at Yale Medical Center
S Flow cytometry analysis
1. Polystyrene microspore bead with capture antibody
2. Capture antibody binds analyte
3. Fluorescence labeled reported antibody binds to captured analyte
4. Bead identification and reporter quantity analyzed by laser detection
![Page 15: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/15.jpg)
Luminex Results
Cytokines analyzed:
S GROa
S IL-1b
S IL-6
S IL-8
S IL-10
S IL-12
S IL-17
S G-CSF
S GM-CSF
S IFN-g
S MCP-1 (MCAF)
S MIP-1a
S MIP-1b
S RANTES
S TNF-a
S VEGF
![Page 16: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/16.jpg)
Luminex Cytokine AnalysisIncreased levels of the following cytokines in healing ulcerations
Cytokine Function
IL-6Secreted by macrophages and T-cells to
stimulate immune response
IL-8 Induces chemotaxis and promotes angiogenesis
G-CSFInduces chemotaxis of stem cells for production
of RBCs, WBCs, platelets
GROa
Secreted by melanoma cells. Mitogenic
properties; neutrophil chemotaxis, and mediator
of angiogenesis
![Page 17: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/17.jpg)
UPLC-MS Analysis
S Performed at the Midwest Proteome Center, Rosalind
Franklin University of Medicine and Science
![Page 18: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/18.jpg)
UPLC-MS Proteomic AnalysisQuantitative differences of proteins in healing versus non-healing wounds
Gene Protein Function
CXCL7Chemokine (C-X-C motif)
ligand 7
Stimulates mitogenesis and glucose
metabolism, and synthesis of
extracellular matrix and plasminogen
activator
GDIR2Rho GDP-dissociation
inhibitor 2
Regulates the GDP/GTP exchange
reaction and reorganization of the
actin cytoskeleton
ALDOAFructose-bisphosphate
aldolase A
Glycolysis and gluconeogenesis
Scaffolding protein
FRIL Ferritin light chain Iron homeostasis
![Page 19: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/19.jpg)
Study Limitations
S Low patient enrollment
S Limited resources prevented inclusion of additional, potentially
important, parameters (ex. pH of the wound, HbA1c, patient’s Rx
involvement)
![Page 20: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/20.jpg)
Future Work
S Inclusion of chronic wounds of various etiologies
S Longitudinal study following patients over time
S Biomarker identification and quantification to alter treatment modalities
S Biomarker incorporation into pharmaceutical treatment options
![Page 21: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/21.jpg)
Acknowledgments
S Marc J. Glucksman, PhD
S Keith D. Philibert, MS
S Stephanie Wu, DPM, MS, FACFAS
S Jacquelyn Ortiz and the staff at Rosalind Franklin University
Health Clinic
S Xinli Yang, PhD
![Page 22: Biomarker Discovery: Prognosis and Management of Chronic ... Discovery.pdf · Diabetes, Chronic Wounds and U.S. Healthcare SCost of caring for chronic wounds exceeds $50 billion each](https://reader033.vdocuments.mx/reader033/viewer/2022052718/5f049a2d7e708231d40ec88c/html5/thumbnails/22.jpg)
Questions